---
title: Dalpiciclib
slug: dalpiciclib
qid: 
snapshot: enwiki-001357571692
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1357571692
tags: [100989226, 106462794, 109487192, 23118434, 23468805, 23603337, 27132159, 27743200, 28696559, 33905804, 37750075, 50769796, 60367775, 60812010, 67819776, 72504547, 90828263]
---

# Dalpiciclib

> [!note] Provenance
> Snapshot `enwiki-001357571692` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1357571692> · Licensed CC BY-SA 4.0

Dalpiciclib is a drug for the treatment of various forms of cancer. In China, dalpiciclib is approved for use in combination with fulvestrant for treatment of HR-positive, HER2-negative recurrent, or metastatic breast cancer in patients who have progressed after previous endocrine therapy. Dalpicicilib is a CDK inhibitor that targets the CDK4 and CDK6 isoforms.

Dalpiciclib is a drug for the treatment of various forms of cancer. In China, dalpiciclib is approved for use in combination with fulvestrant for treatment of HR-positive, HER2-negative recurrent, or metastatic breast cancer in patients who have progressed after previous endocrine therapy. Dalpicicilib is a CDK inhibitor that targets the CDK4 and CDK6 isoforms.
